Tibbs
Adam Tibbs, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20100235206 | Methods and Systems for Modular Buildings - The present invention provides a multifunctional building panel which may comprise a sensor to measure an interior condition and an exterior condition and generate a signal in response, along with systems and methods for designing, optimizing and constructing modular buildings, including buildings constructed at least in part of multifunctional building panels, by utilizing a priority distribution ranking as an optimization constraint. | 09-16-2010 |
Andy Tibbs, Roswell, GA US
Patent application number | Description | Published |
---|---|---|
20140222711 | Systems and Methods for Parcel Delivery to Alternate Delivery Locations - A system, in various embodiments, is configured to redirect undeliverable parcels to alternate delivery locations. The parcels may be undeliverable due to an unavailability of an intended recipient of the parcels to sign for the parcels or otherwise take delivery of the parcels at the delivery address. The system may be configured to determine a suitable alternate delivery location based at least in part on: one or more parcel recipient preferences, one or more parcel shipper preferences, a location of the delivery address, etc. The system may be further configured to notify the parcel recipient of a redirection of the parcel to the alternate delivery address. | 08-07-2014 |
Andy W. Tibbs, Earlham, IA US
Patent application number | Description | Published |
---|---|---|
20120125008 | LOW CALORIFIC VALUE FUEL COMBUSTION SYSTEMS FOR GAS TURBINE ENGINES - A combustion system for a gas turbine engine includes a housing defining a pressure vessel. A master injector is mounted to the housing for injecting fuel along a central axis defined through the pressure vessel. A plurality of slave injectors is included. Each slave injector is disposed radially outward of and substantially parallel to the master injector for injecting fuel and air in an injection plume radially outward of fuel injected through the master injector. The master injector and slave injectors are configured and adapted so the injection plume of the master injector intersects with the injection plumes of the slave injectors. The slave injectors can be staged for reduced power operation. | 05-24-2012 |
Dawn Ann Tibbs, Benson, AZ US
Patent application number | Description | Published |
---|---|---|
20140127296 | Pharmaceutical preparation and method for treatment of diabetes - A pharmaceutical composition for use in oral medication for the treatment of diabetes mellitus can include an antacid agent with an enteric coating, which permits the antacid agent to be delivered in the small intestines where it reduces acidity thereby causing a lowering of blood sugar levels. The pharmaceutical composition can be packaged in various tablet forms, including standard tablets and multiple pellet tablets. The pharmaceutical composition can further include an enteric coated gastric acid secretion inhibitor. Also disclosed is a method for the treatment of diabetes mellitus. | 05-08-2014 |
Gareth R. Tibbs, New York, NY US
Patent application number | Description | Published |
---|---|---|
20130005718 | COMPOSITIONS AND METHODS OF TREATING CHRONIC PAIN BY ADMINISTERING PROPOFOL DERIVATIVES - Compositions and methods for managing or treating chronic pain are provided. More particularly, methods are provided for managing or treating chronic pain by administering to a patient in need thereof an effective amount of propofol or a propofol derivative having limited anesthetic properties. Methods of modulating HCN channel gating are also provided. Pharmaceutically acceptable compositions for, e.g., modulating HCN channel gating are further provided. | 01-03-2013 |
Kenneth John Tibbs, Benson, AZ US
Patent application number | Description | Published |
---|---|---|
20140127296 | Pharmaceutical preparation and method for treatment of diabetes - A pharmaceutical composition for use in oral medication for the treatment of diabetes mellitus can include an antacid agent with an enteric coating, which permits the antacid agent to be delivered in the small intestines where it reduces acidity thereby causing a lowering of blood sugar levels. The pharmaceutical composition can be packaged in various tablet forms, including standard tablets and multiple pellet tablets. The pharmaceutical composition can further include an enteric coated gastric acid secretion inhibitor. Also disclosed is a method for the treatment of diabetes mellitus. | 05-08-2014 |
Stacey L. Tibbs, Colonial Heights, VA US
Patent application number | Description | Published |
---|---|---|
20140137792 | Assay Wick With Analyte Fluid Sufficiency Indicator - A wick for use in determining sufficiency of an amount of analyte fluid provided to an analyte test section of an assay device is provided. The wick comprises a primary wick portion attached or attachable to the analyte test section so as to be in fluid communication therewith. The primary wick portion has a receiving surface adapted for receiving the analyte fluid and is configured to draw the analyte fluid from a first area to a second area of the primary wick portion. The assay wick further comprises an indicator portion having a contrasting visual characteristic. The indicator surface is covered by at least a portion of the primary wick portion, which comprises a wicking material that becomes more light transmissive when wetted by the analyte fluid. The contrasting visual characteristic is viewable through the at least a portion of the primary wick portion only when the at least a portion of the primary wick portion is suffused by the analyte fluid. | 05-22-2014 |
Tracie Tibbs, Charleston, SC US
Patent application number | Description | Published |
---|---|---|
20090186200 | 2,5-DI(METHOXYANILINO) TEREPHTHALIC ACID POLYMORPHS AND QUINACRIDONES REALIZED THEREFROM - 2,5-di(p-methoxyanilino)terephthalic acid crystal types I and II are made by controlling the pH during the recovery of the oxidized product of the condensation of dimethylsuccinyl succinate with p-methoxyaniline. The resulting 2,5-di(p-methoxyanilino)-terephthalic acid can be converted into 2,9-dimethoxyquinacridone or a solid solution thereof having controlled characteristics. | 07-23-2009 |
20110209643 | Novel Crystal Forms of Quinacridones Made from 2,9-Dimethoxyquinacridone and 2,9-Dichloroquinacridone - Novel crystal forms of solid solutions of 2,9-dimethyoxyquinacridone and 2,9-dichloroquinacridone. The crystal forms may be formed by a process comprising the steps of: a) heating a mixture of 2,5-di(4-methoxyanilino)terephthalic acid, and 2,5-di(4-chloroanilino)terephthalic acid in polyphorsphoric acid at a temperature less than 1050 C to form a mixture of 2,9-dimethoxyquinacridone and 2,9-dichloroquinacridone; b) combining the mixture of 2,9-dimethoxyquinacridone and 2,9-dichloro-quinacridone with water; and c) heating the mixture of 2,9-dimethoxyquinacridone and 2,9-dichloroquinacridone at a temperature not more than 110° C. Another crystal form may be formed by the process of heating a mixture of 2,9-dimethoxyquinacridone and 2,9-dichloroquinacridone in a polar aprotic solvent. These products are may be used for coloring fibers, plastics, paints, coatings, printing inks, color filters, cosmetics, automotive coatings, textiles, fibers, powder coatings, in-mold coatings, laminate films, and the like. | 09-01-2011 |
20120260823 | NOVEL CRYSTAL FORMS OF QUINACRIDONES MADE FROM 2,9-DIMETHOXYQUINACRIDONE AND 2,9-DICHLOROQUINACRIDONE - Novel crystal forms of solid solutions of 2,9-dimethyoxyquinacridone and 2,9-dichloroquinacridone. The crystal forms may be formed by a process comprising the steps of: a) heating a mixture of 2,5-di(4-methoxyanilino)terephthalic acid, and 2,5-di(4-chloroanilino)terephthalic acid in polyphorsphoric acid at a temperature less than 1050 C to form a mixture of 2,9-dimethoxyquinacridone and 2,9-dichloroquinacridone; b) combining the mixture of 2,9-dimethoxyquinacridone and 2,9-dichloroquinacridone with water; and c) heating the mixture of 2,9-dimethoxyquinacridone and 2,9-dichloroquinacridone at a temperature not more than 110° C. Another crystal form may be formed by the process of heating a mixture of 2,9-dimethoxyquinacridone and 2,9-dichloroquinacridone in a polar aprotic solvent. These products are may be used for coloring fibers, plastics, paints, coatings, printing inks, color filters, cosmetics, automotive coatings, textiles, fibers, powder coatings, in-mold coatings, laminate films, and the like. | 10-18-2012 |
20130053568 | 2,5-DI(METHOXYANILINO) TEREPHTHALIC ACID POLYMORPHS AND QUINACRIDONES REALIZED THEREFROM2,5-DI(METHOXYANILINO) TEREPHTHALIC ACID POLYMORPHS AND QUINACRIDONES REALIZED THEREFROM - 2,5-di(p-methoxyanilino)terephthalic acid crystal types I and II are made by controlling the pH during the recovery of the oxidized product of the condensation of dimethylsuccinyl succinate with p-methoxyaniline. The resulting 2,5-di(p-methoxyanilino)-terephthalic acid can be converted into 2,9-dimethoxyquinacridone or a solid solution thereof having controlled characteristics. | 02-28-2013 |